Skip to main content
Top
Published in: Diabetologia 2/2020

01-02-2020 | Insulins | Article

Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum period

Authors: Thaddeus P. Waters, Shin Y. Kim, Andrea J. Sharma, Pamela Schnellinger, Janet K. Bobo, Robert T. Woodruff, Lisa A. Cubbins, Mary Haghiac, Judi Minium, Larraine Presley, Honor Wolfe, Sylvie Hauguel-de Mouzon, William Adams, Patrick M. Catalano

Published in: Diabetologia | Issue 2/2020

Login to get access

Abstract

Aims/hypothesis

This study aimed to determine, in women with gestational diabetes (GDM), the changes in insulin sensitivity (Matsuda Insulin Sensitivity Index; ISOGTT), insulin response and disposition index (DI) from late pregnancy (34–37 weeks gestation, T1), to early postpartum (1–5 days, T2) and late postpartum (6–12 weeks, T3). A secondary aim was to correlate the longitudinal changes in maternal lipids, adipokines, cytokines and weight in relation to the changes in ISOGTT, insulin response and DI.

Methods

ISOGTT, insulin response and DI were calculated at the three time points (T1, T2 and T3) using the results of a 75 g OGTT. Adipokines, cytokines and lipids were measured prior to each OGTT. Linear mixed-effects models were used to compare changes across each time point. Changes in ISOGTT, insulin response and DI were correlated with changes in maternal adipokines, cytokines and lipids at each time point.

Results

A total of 27 women completed all assessments. Compared with T1, ISOGTT was 11.20 (95% CI 8.09, 14.31) units higher at 1–5 days postpartum (p < 0.001) and was 5.49 (95% CI 2.38, 8.60) units higher at 6–12 weeks postpartum (p < 0.001). Compared with T1, insulin response values were 699.6 (95% CI 957.5, 441.6) units lower at T2 (p < 0.001) and were 356.3 (95% CI 614.3, 98.3) units lower at T3 (p = 0.004). Compared with T1, the DI was 6434.1 (95% CI 2486.2, 10,381.0) units higher at T2 (p = 0.001) and was 4262.0 (95% CI 314.6, 8209.3) units higher at T3 (p = 0.03). There was a decrease in mean cholesterol, triacylglycerol, LDL-cholesterol and VLDL-cholesterol from T1 to T2 (all p < 0.001), and an increase in mean C-reactive protein, IL-6 and IL-8 from T1 to T2 (all p < 0.001). Mean leptin decreased from T1 to T2 (p = 0.001). There was no significant change in mean adiponectin (p = 0.99) or TNF-α (p = 0.81) from T1 to T2. The mean maternal BMI decreased from T1 to T2 (p = 0.001) and T3 (p < 0.001). There were no significant correlations between any measure of change in ISOGTT, insulin response and DI and change in maternal cytokines, adipokines, lipids or weight from T1 to T2.

Conclusions/interpretation

In women with GDM, delivery was associated with improvement in both insulin sensitivity and insulin production within the first few days. Improvement in insulin production persisted for 6–12 weeks, but insulin sensitivity deteriorated slightly. These changes in glucose metabolism were not associated to changes in lipids, leptin, inflammation markers or body weight.

Trial registration

Appendix
Available only for authorised users
Literature
1.
go back to reference Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E (2015) Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Matern Child Health J 19(3):635–642CrossRef Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E (2015) Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Matern Child Health J 19(3):635–642CrossRef
18.
go back to reference American Diabetes Association (2015) Classification and Diagnosis of Diabetes. Diabetes Care 38 Suppl 1:S8–S16CrossRef American Diabetes Association (2015) Classification and Diagnosis of Diabetes. Diabetes Care 38 Suppl 1:S8–S16CrossRef
22.
go back to reference Kenward MG, Roger JH (1997) Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983–997CrossRef Kenward MG, Roger JH (1997) Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983–997CrossRef
30.
go back to reference Catalano PM, Tyzbir ED, Wolfe RR et al (1993) Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Phys 264(1 Pt 1):E60–E67 Catalano PM, Tyzbir ED, Wolfe RR et al (1993) Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Phys 264(1 Pt 1):E60–E67
Metadata
Title
Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum period
Authors
Thaddeus P. Waters
Shin Y. Kim
Andrea J. Sharma
Pamela Schnellinger
Janet K. Bobo
Robert T. Woodruff
Lisa A. Cubbins
Mary Haghiac
Judi Minium
Larraine Presley
Honor Wolfe
Sylvie Hauguel-de Mouzon
William Adams
Patrick M. Catalano
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-05051-0

Other articles of this Issue 2/2020

Diabetologia 2/2020 Go to the issue

Up Front

Up front

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.